Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Advik Laboratories Ltd (NSE: ADVIKLA), ISIN INE537C01019 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ADVIKLA last traded at ₹2.08 (+0.00%), with a 52-week range of ₹1.57 to ₹2.08 (as of 21 Sep 2026).
Shareholding as of Mar 2025: promoters 35.89%, FIIs 0.00%, DIIs 0.58%, mutual funds 0.00%.
Data sourced from NSE and BSE filings. Educational — not investment advice.